AMAG PHARMACEUTICALS, INC. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMAG PHARMACEUTICALS, INC. for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Option Exercise | A | 21.00 | 20,000 | 420,000 | 20,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Sell | S | 20.80 | 770 | 16,016 | 52,854 | 53.6 K to 52.9 K (-1.44 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 21.00 | 1,011 | 21,231 | 53,624 | 54.6 K to 53.6 K (-1.85 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 10,000 | 0 | 54,635 | 44.6 K to 54.6 K (+22.40 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 12,000 | 0 | 44,635 | 32.6 K to 44.6 K (+36.77 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 19.65 | 869 | 17,076 | 32,635 | 33.5 K to 32.6 K (-2.59 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 21.00 | 100,000 | 2,100,000 | 100,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 21.00 | 10,546 | 221,466 | 353,015 | 363.6 K to 353 K (-2.90 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 45,500 | 0 | 363,561 | 318.1 K to 363.6 K (+14.31 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 45,500 | 0 | 318,061 | 272.6 K to 318.1 K (+16.69 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Option Exercise | A | 21.00 | 22,000 | 462,000 | 22,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Payment of Exercise | F | 21.00 | 1,700 | 35,700 | 51,636 | 53.3 K to 51.6 K (-3.19 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Grant | A | 0.00 | 12,000 | 0 | 53,336 | 41.3 K to 53.3 K (+29.03 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | EVP, CMO | Grant | A | 0.00 | 13,000 | 0 | 41,336 | 28.3 K to 41.3 K (+45.88 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Option Exercise | A | 21.00 | 24,000 | 504,000 | 24,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Payment of Exercise | F | 21.00 | 4,193 | 88,053 | 66,324 | 70.5 K to 66.3 K (-5.95 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 70,517 | 58.5 K to 70.5 K (+20.51 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 58,517 | 48.5 K to 58.5 K (+20.61 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Option Exercise | A | 21.00 | 24,000 | 504,000 | 24,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Payment of Exercise | F | 21.00 | 854 | 17,934 | 53,294 | 54.1 K to 53.3 K (-1.58 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 54,148 | 44.1 K to 54.1 K (+22.65 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 44,148 | 34.1 K to 44.1 K (+29.28 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Option Exercise | A | 21.00 | 20,000 | 420,000 | 20,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Payment of Exercise | F | 21.00 | 3,549 | 74,529 | 56,918 | 60.5 K to 56.9 K (-5.87 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Grant | A | 0.00 | 9,000 | 0 | 60,467 | 51.5 K to 60.5 K (+17.49 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Grant | A | 0.00 | 9,000 | 0 | 51,467 | 42.5 K to 51.5 K (+21.19 %) |